| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | Chief Financial Officer | Class B Common Stock, par value $0.0001 per share | 125,000 | $1,250,000 | $10.00 | 05 Aug 2021 | Direct |
| SelectQuote, Inc. | Director | Restricted Stock Units | 106,250 | 11 Nov 2025 | Direct | ||
| SelectQuote, Inc. | Director | No securities are beneficially owned. | 0 | 28 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLQT | SelectQuote, Inc. | 11 Nov 2025 | 1 | $0 | 4 | Director | 13 Nov 2025, 17:00 |
| SLQT | SelectQuote, Inc. | 28 Feb 2025 | 1 | $0 | 4 | Director | 04 Mar 2025, 18:41 |
| SLQT | SelectQuote, Inc. | 28 Feb 2025 | 0 | $0 | 3 | Director | 04 Mar 2025, 18:35 |
| /report/000089924321032272-wolfe-chris-2021-08-05 | DA32 Life Science Tech Acquisition Corp. | 05 Aug 2021 | 1 | $0 | 4 | Chief Financial Officer | 09 Aug 2021, 20:44 |
| /report/000089924321030183-wolfe-chris-2021-07-27 | DA32 Life Science Tech Acquisition Corp. | 27 Jul 2021 | 0 | $0 | 3 | Chief Financial Officer | 27 Jul 2021, 20:08 |